You are here

  • Home
  • Archive
  • Volume 22, Issue 5
  • In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids

Citation Tools

Article menu
Download PDFPDF
Commentary
General medicine
In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Cazzola M, Rogliani P
In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV 1 than long-acting beta-agonists plus inhaled corticosteroids
BMJ Evidence-Based Medicine 2017;22:183-184.